Exponent (EXPO)
Market Price (2/16/2026): $66.07 | Market Cap: $3.4 BilSector: Industrials | Industry: Research & Consulting Services
Exponent (EXPO)
Market Price (2/16/2026): $66.07Market Cap: $3.4 BilSector: IndustrialsIndustry: Research & Consulting Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22% | Weak multi-year price returns2Y Excs Rtn is -48%, 3Y Excs Rtn is -101% | Key risksEXPO key risks include [1] its dependence on attracting and retaining highly specialized personnel, Show more. |
| Low stock price volatilityVol 12M is 30% | ||
| Megatrend and thematic driversMegatrends include Advanced Materials, Electric Vehicles & Autonomous Driving, and Automation & Robotics. Themes include Lightweight Composites, Show more. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22% |
| Low stock price volatilityVol 12M is 30% |
| Megatrend and thematic driversMegatrends include Advanced Materials, Electric Vehicles & Autonomous Driving, and Automation & Robotics. Themes include Lightweight Composites, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -48%, 3Y Excs Rtn is -101% |
| Key risksEXPO key risks include [1] its dependence on attracting and retaining highly specialized personnel, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Exponent (EXPO) stock has lost about 5% since 10/31/2025 because of the following key factors:
1. Full-Year 2025 Financial Performance and Margin Contraction. Despite Exponent reporting a strong fourth quarter of 2025 that surpassed analyst revenue and earnings per share expectations, the full fiscal year 2025 showed a 3% decrease in net income to $106 million and an 80 basis point reduction in the EBITDA margin to 27.6% compared to fiscal year 2024. This decline in overall annual profitability and efficiency, attributed partly to specific costs such as a managers' meeting and a land lease renewal, likely tempered investor enthusiasm for the longer-term outlook after the initial positive reaction to the Q4 results.
2. Deceleration in Projected Revenue Growth. While Exponent's management forecasted high-single-digit revenue growth for the first quarter and full-year 2026, sell-side analysts anticipate a deceleration in revenue growth to 4.1% over the next 12 months. This projected growth rate is notably lower than the company's annualized revenue growth of 5.6% over the last two years and its 8% compounded annual growth rate over the past five years, suggesting a more conservative outlook for future top-line expansion that could weigh on investor sentiment.
Show more
1. Full-Year 2025 Financial Performance and Margin Contraction. Despite Exponent reporting a strong fourth quarter of 2025 that surpassed analyst revenue and earnings per share expectations, the full fiscal year 2025 showed a 3% decrease in net income to $106 million and an 80 basis point reduction in the EBITDA margin to 27.6% compared to fiscal year 2024. This decline in overall annual profitability and efficiency, attributed partly to specific costs such as a managers' meeting and a land lease renewal, likely tempered investor enthusiasm for the longer-term outlook after the initial positive reaction to the Q4 results.
2. Deceleration in Projected Revenue Growth. While Exponent's management forecasted high-single-digit revenue growth for the first quarter and full-year 2026, sell-side analysts anticipate a deceleration in revenue growth to 4.1% over the next 12 months. This projected growth rate is notably lower than the company's annualized revenue growth of 5.6% over the last two years and its 8% compounded annual growth rate over the past five years, suggesting a more conservative outlook for future top-line expansion that could weigh on investor sentiment.
Show more
Stock Movement Drivers
Fundamental Drivers
The -5.3% change in EXPO stock from 10/31/2025 to 2/15/2026 was primarily driven by a -7.7% change in the company's P/E Multiple.| (LTM values as of) | 10312025 | 2152026 | Change |
|---|---|---|---|
| Stock Price ($) | 70.52 | 66.79 | -5.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 561 | 571 | 1.9% |
| Net Income Margin (%) | 18.3% | 18.3% | 0.0% |
| P/E Multiple | 35.1 | 32.4 | -7.7% |
| Shares Outstanding (Mil) | 51 | 51 | 0.6% |
| Cumulative Contribution | -5.3% |
Market Drivers
10/31/2025 to 2/15/2026| Return | Correlation | |
|---|---|---|
| EXPO | -5.3% | |
| Market (SPY) | -0.0% | 49.1% |
| Sector (XLI) | 12.3% | 43.4% |
Fundamental Drivers
The -2.4% change in EXPO stock from 7/31/2025 to 2/15/2026 was primarily driven by a -2.8% change in the company's Net Income Margin (%).| (LTM values as of) | 7312025 | 2152026 | Change |
|---|---|---|---|
| Stock Price ($) | 68.40 | 66.79 | -2.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 559 | 571 | 2.2% |
| Net Income Margin (%) | 18.9% | 18.3% | -2.8% |
| P/E Multiple | 33.2 | 32.4 | -2.5% |
| Shares Outstanding (Mil) | 51 | 51 | 0.8% |
| Cumulative Contribution | -2.4% |
Market Drivers
7/31/2025 to 2/15/2026| Return | Correlation | |
|---|---|---|
| EXPO | -2.4% | |
| Market (SPY) | 8.2% | 40.0% |
| Sector (XLI) | 15.1% | 43.4% |
Fundamental Drivers
The -26.0% change in EXPO stock from 1/31/2025 to 2/15/2026 was primarily driven by a -25.4% change in the company's P/E Multiple.| (LTM values as of) | 1312025 | 2152026 | Change |
|---|---|---|---|
| Stock Price ($) | 90.24 | 66.79 | -26.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 545 | 571 | 4.9% |
| Net Income Margin (%) | 19.5% | 18.3% | -6.0% |
| P/E Multiple | 43.4 | 32.4 | -25.4% |
| Shares Outstanding (Mil) | 51 | 51 | 0.6% |
| Cumulative Contribution | -26.0% |
Market Drivers
1/31/2025 to 2/15/2026| Return | Correlation | |
|---|---|---|
| EXPO | -26.0% | |
| Market (SPY) | 14.3% | 42.2% |
| Sector (XLI) | 27.2% | 46.1% |
Fundamental Drivers
The -32.3% change in EXPO stock from 1/31/2023 to 2/15/2026 was primarily driven by a -36.1% change in the company's P/E Multiple.| (LTM values as of) | 1312023 | 2152026 | Change |
|---|---|---|---|
| Stock Price ($) | 98.62 | 66.79 | -32.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 499 | 571 | 14.4% |
| Net Income Margin (%) | 20.1% | 18.3% | -8.5% |
| P/E Multiple | 50.7 | 32.4 | -36.1% |
| Shares Outstanding (Mil) | 51 | 51 | 1.2% |
| Cumulative Contribution | -32.3% |
Market Drivers
1/31/2023 to 2/15/2026| Return | Correlation | |
|---|---|---|
| EXPO | -32.3% | |
| Market (SPY) | 74.0% | 38.4% |
| Sector (XLI) | 78.5% | 45.9% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| EXPO Return | 31% | -14% | -10% | 2% | -21% | -3% | -21% |
| Peers Return | 42% | -3% | 19% | 9% | -12% | -4% | 51% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -0% | 82% |
Monthly Win Rates [3] | |||||||
| EXPO Win Rate | 58% | 42% | 50% | 75% | 33% | 50% | |
| Peers Win Rate | 63% | 52% | 55% | 63% | 52% | 50% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| EXPO Max Drawdown | -8% | -30% | -28% | -15% | -26% | -3% | |
| Peers Max Drawdown | -4% | -20% | -7% | -7% | -24% | -6% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: TTEK, J, ACM, ICFI, FCN. See EXPO Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/13/2026 (YTD)
How Low Can It Go
| Event | EXPO | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -43.5% | -25.4% |
| % Gain to Breakeven | 77.0% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -27.9% | -33.9% |
| % Gain to Breakeven | 38.8% | 51.3% |
| Time to Breakeven | 127 days | 148 days |
| 2018 Correction | ||
| % Loss | -14.4% | -19.8% |
| % Gain to Breakeven | 16.8% | 24.7% |
| Time to Breakeven | 55 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -46.2% | -56.8% |
| % Gain to Breakeven | 85.8% | 131.3% |
| Time to Breakeven | 648 days | 1,480 days |
Compare to TTEK, J, ACM, ICFI, FCN
In The Past
Exponent's stock fell -43.5% during the 2022 Inflation Shock from a high on 12/8/2021. A -43.5% loss requires a 77.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Exponent (EXPO)
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
AI Analysis | Feedback
Here are 1-2 brief analogies to describe Exponent (EXPO):
- The **McKinsey & Company** for highly specialized scientific and engineering problem-solving, often involving failure analysis and litigation support.
- Like **Deloitte Consulting** or **Accenture**, but exclusively focused on deep technical investigations, product safety, and scientific expert testimony rather than IT or business strategy.
AI Analysis | Feedback
```html- Engineering & Scientific Consulting: Provides deep technical expertise to solve complex engineering, scientific, and business challenges across various industries.
- Litigation & Expert Witness Support: Offers independent scientific and engineering analysis and expert testimony for legal disputes and regulatory proceedings.
- Failure Analysis & Incident Investigation: Investigates the root causes of failures, accidents, and incidents involving products, materials, or systems.
- Product Design & Development Support: Assists clients with the safety, reliability, and performance aspects of product design, testing, and regulatory compliance.
- Environmental & Health Consulting: Assesses health and environmental risks, exposure pathways, and regulatory compliance related to chemicals, contaminants, and public health.
AI Analysis | Feedback
Exponent (symbol: EXPO) is a scientific and engineering consulting firm that primarily sells its services to other companies and organizations, not individuals.
Due to the confidential nature of their consulting engagements and client relationships, Exponent does not publicly disclose the names of its specific major customer companies. However, based on their public filings and investor materials, their client base consists of various types of organizations across a wide range of industries.
The major categories of customers Exponent serves include:
- Corporations: Companies across diverse sectors such as manufacturing, technology, automotive, energy, consumer products, and healthcare. These clients seek expert analysis for product development, failure analysis, regulatory compliance, risk management, and litigation support.
- Law Firms: Representing clients in complex litigation, including product liability, intellectual property, environmental, and construction defect cases, requiring expert witness testimony, litigation consulting, and technical analysis.
- Insurance Carriers: Utilizing Exponent's expertise for accident investigation, claim analysis, subrogation, and risk assessment related to various insured events, including property damage, personal injury, and casualty claims.
AI Analysis | Feedback
nullAI Analysis | Feedback
Catherine Ford Corrigan, Ph.D. President, Chief Executive Officer and Director
Dr. Corrigan joined Exponent in 1996 and became CEO in 2018. Her early focus at the company was on the biomechanics of human injury. Over her career at Exponent, she has held various leadership roles, including being promoted to principal in 2002, corporate vice president in 2005, and group vice president to lead the Transportation Group in 2012. She was named president of Exponent, Inc. in July 2016.
Richard L. Schlenker Jr. Executive Vice President, Chief Financial Officer and Corporate Secretary
Mr. Schlenker joined Exponent in October 1990 and has served as Chief Financial Officer since July 1999. He holds a B.S. in finance from the University of Southern California. Prior to his CFO role, he held various positions in finance and accounting, including Business Manager for Exponent Failure Analysis Associates until 1996, Manager of Corporate Development, and Director of Corporate Development. He was appointed Corporate Secretary in November 1997.
Subbaiah V. Malladi, Ph.D., P.E. Group Vice President and Principal Engineer
Dr. Malladi is a Group Vice President and a Principal Engineer at Exponent.
Joseph Sala, Ph.D. Corporate Vice President, Practice Director and Principal Scientist
Dr. Sala serves as Corporate Vice President, Practice Director, and Principal Scientist at Exponent.
Maureen Reitman, Sc.D., P.E., NAE, FSPE Group Vice President and Principal Engineer
Dr. Reitman is a Group Vice President and a Principal Engineer at Exponent.
AI Analysis | Feedback
The key risks to Exponent's business (EXPO) primarily revolve around its human capital, the evolving technological landscape, and broader economic conditions.
- Reliance on Key Personnel and Impact of Technological Advancements: Exponent's business model is deeply dependent on its highly specialized and credentialed workforce, consisting of scientists, engineers, and other experts. Consequently, the ability to attract, retain, and effectively utilize these key employees is paramount to its success. Furthermore, advances in automation and artificial intelligence (AI) pose a significant risk by potentially reducing the demand for some of Exponent's specialized consulting services, which could intensify competition and exert pressure on pricing and long-term revenue growth.
- General Economic Conditions and Demand for Services: Exponent's demand for services is sensitive to general and industry-specific economic conditions. Economic downturns or adverse changes in particular industries can lead to a decline in client engagements, affect clients' ability to utilize services at previous levels, and introduce risks related to the timing of engagements, as well as credit and collectability.
- Regulatory Changes and Liabilities from Professional Services: The company faces risks associated with changes in tort reform and government regulation that could impact its business operations and potential liabilities. Moreover, as a consulting firm providing expert analysis and testimony, Exponent is exposed to liabilities resulting from claims made against it in the course of its professional services.
AI Analysis | Feedback
nullAI Analysis | Feedback
The addressable market for Exponent's main products and services, which primarily consist of engineering and scientific consulting services, can be identified at both a global and U.S. regional level.
Global Market
The global engineering consulting services market was valued at approximately USD 175.43 billion in 2025 and is projected to reach USD 348.79 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.93% from 2025 to 2034. Another estimate indicates the market size was USD 202.5 billion in 2025 and is expected to grow to USD 300 billion by 2035, with a CAGR of around 4.0% during that period.
U.S. Market
In the United States, the engineering services market, which includes consulting, reached approximately USD 388.56 billion in 2025. This market is projected to grow to USD 507.35 billion by 2030, exhibiting a CAGR of 5.48%. Another source estimates the U.S. engineering services market to be USD 350.8 billion in 2025. Additionally, the U.S. market is projected to reach USD 581.0 billion by 2030, with a CAGR of 6.2% from 2025 to 2030.
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for Exponent (EXPO) over the next 2-3 years:- Strong Demand for Dispute-Related Work: Exponent anticipates continued robust demand for its dispute-related consulting services, particularly within the energy, transportation, life sciences, and construction sectors. This reactive work, often addressing urgent client challenges such as litigation or failure analysis, has been a primary growth driver.
- Growth in Proactive Risk Management and Regulatory Consulting: The company expects ongoing momentum in proactive engagements, including risk management and asset integrity projects in the utility sector and regulatory consulting in chemicals. This also extends to an intensifying focus on safety, risk management, and product reliability across various industries.
- Expansion into AI Integration and Emerging Technologies: Exponent is actively involved in early-stage initiatives tied to transformative technologies, including AI integration. The firm's deep roots in failure analysis are driving growth as technical challenges become more novel and complex, including emerging fields such as advanced driver assistance systems, battery storage, and wearables.
- Strategic Headcount Growth and Increased Utilization: Exponent plans to increase its technical headcount by approximately 4-6% in high-demand sectors in 2026, aiming to sustain utilization levels. Increased headcount allows the company to take on more projects and leverage its multidisciplinary expertise.
- Realized Rate Increases: The company projects realized rate increases of 4% to 5% for the fourth quarter and full year 2025, reflecting its premium position in the marketplace and differentiated expertise. This ability to command higher rates contributes directly to revenue growth.
AI Analysis | Feedback
Share Repurchases
- Exponent repurchased $155.9 million of common stock in fiscal year 2022. The Board of Directors authorized a $150 million expansion to its share repurchase program in February 2022, bringing the total available for repurchase to approximately $179.5 million.
- In 2023, the company repurchased $24.2 million in common stock. For the full year 2024, share repurchases amounted to $5.7 million.
- An additional $100 million was authorized for the share repurchase program on October 30, 2025, adding to the $21.6 million that remained available as of October 3, 2025.
Share Issuance
- Stock-based compensation expense was $20.4 million in fiscal year 2022.
- For the first quarter of 2023, stock-based compensation expense was $7.1 million.
- The estimated stock-based compensation expense for the full year 2024 was between $23 million and $23.5 million.
Capital Expenditures
- Capital expenditures were approximately $12.6 million in fiscal year 2022, driven by increased investment in corporate infrastructure.
- In fiscal year 2023, capital expenditures increased to approximately $18.7 million.
- For fiscal year 2024, capital expenditures were approximately $6.9 million, with an expectation of $10 million to $12 million for the full year 2025.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 82.66 |
| Mkt Cap | 7.4 |
| Rev LTM | 4,463 |
| Op Inc LTM | 491 |
| FCF LTM | 319 |
| FCF 3Y Avg | 277 |
| CFO LTM | 339 |
| CFO 3Y Avg | 312 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -1.3% |
| Rev Chg 3Y Avg | 6.8% |
| Rev Chg Q | -0.7% |
| QoQ Delta Rev Chg LTM | -0.2% |
| Op Mgn LTM | 9.2% |
| Op Mgn 3Y Avg | 8.8% |
| QoQ Delta Op Mgn LTM | 0.2% |
| CFO/Rev LTM | 8.1% |
| CFO/Rev 3Y Avg | 8.2% |
| FCF/Rev LTM | 7.2% |
| FCF/Rev 3Y Avg | 7.5% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 7.4 |
| P/S | 1.3 |
| P/EBIT | 15.9 |
| P/E | 25.9 |
| P/CFO | 17.5 |
| Total Yield | 5.0% |
| Dividend Yield | 0.7% |
| FCF Yield 3Y Avg | 4.6% |
| D/E | 0.2 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -9.3% |
| 3M Rtn | -2.7% |
| 6M Rtn | -6.3% |
| 12M Rtn | -12.2% |
| 3Y Rtn | 0.4% |
| 1M Excs Rtn | -6.0% |
| 3M Excs Rtn | -3.1% |
| 6M Excs Rtn | -13.1% |
| 12M Excs Rtn | -27.6% |
| 3Y Excs Rtn | -66.7% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Engineering and Other Scientific | 447 | 428 | 381 | 319 | 340 |
| Environmental and Health | 90 | 85 | 85 | 81 | 77 |
| Total | 537 | 513 | 466 | 400 | 417 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Engineering and Other Scientific | 154 | 153 | 140 | 101 | 111 |
| Environmental and Health | 28 | 27 | 28 | 27 | 27 |
| Corporate operating expense | -71 | -39 | -59 | -44 | -52 |
| Total | 111 | 141 | 109 | 83 | 85 |
Price Behavior
Price Behavior
| Market Price | $66.79 | |
| Market Cap ($ Bil) | 3.4 | |
| First Trading Date | 08/17/1990 | |
| Distance from 52W High | -23.5% | |
| 50 Days | 200 Days | |
| DMA Price | $72.95 | $72.06 |
| DMA Trend | down | up |
| Distance from DMA | -8.4% | -7.3% |
| 3M | 1YR | |
| Volatility | 41.0% | 29.6% |
| Downside Capture | 194.43 | 108.57 |
| Upside Capture | 155.14 | 67.67 |
| Correlation (SPY) | 50.8% | 42.8% |
EXPO Betas & Captures as of 1/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.39 | 0.98 | 0.82 | 0.70 | 0.56 | 0.73 |
| Up Beta | 2.47 | 1.32 | 0.90 | 1.36 | 0.62 | 0.72 |
| Down Beta | 0.66 | 0.37 | 0.28 | -0.02 | 0.24 | 0.40 |
| Up Capture | 185% | 108% | 107% | 74% | 41% | 46% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 9 | 17 | 29 | 61 | 114 | 360 |
| Down Capture | 159% | 149% | 104% | 89% | 93% | 102% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 11 | 24 | 32 | 64 | 137 | 392 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with EXPO | |
|---|---|---|---|---|
| EXPO | -25.1% | 29.5% | -0.97 | - |
| Sector ETF (XLI) | 27.9% | 19.2% | 1.15 | 46.8% |
| Equity (SPY) | 14.0% | 19.4% | 0.55 | 42.8% |
| Gold (GLD) | 74.3% | 25.3% | 2.17 | 4.9% |
| Commodities (DBC) | 7.0% | 16.7% | 0.24 | 6.0% |
| Real Estate (VNQ) | 7.9% | 16.6% | 0.28 | 40.0% |
| Bitcoin (BTCUSD) | -29.8% | 44.9% | -0.65 | 30.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with EXPO | |
|---|---|---|---|---|
| EXPO | -5.0% | 29.6% | -0.14 | - |
| Sector ETF (XLI) | 15.9% | 17.2% | 0.74 | 51.7% |
| Equity (SPY) | 13.3% | 17.0% | 0.62 | 47.4% |
| Gold (GLD) | 22.1% | 17.0% | 1.06 | 6.6% |
| Commodities (DBC) | 10.5% | 18.9% | 0.44 | 6.9% |
| Real Estate (VNQ) | 5.2% | 18.8% | 0.18 | 49.2% |
| Bitcoin (BTCUSD) | 8.3% | 57.2% | 0.37 | 21.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with EXPO | |
|---|---|---|---|---|
| EXPO | 11.8% | 28.5% | 0.44 | - |
| Sector ETF (XLI) | 15.3% | 19.8% | 0.68 | 52.2% |
| Equity (SPY) | 15.6% | 17.9% | 0.75 | 51.8% |
| Gold (GLD) | 15.3% | 15.6% | 0.82 | 3.9% |
| Commodities (DBC) | 8.1% | 17.6% | 0.38 | 14.9% |
| Real Estate (VNQ) | 6.4% | 20.7% | 0.27 | 47.6% |
| Bitcoin (BTCUSD) | 67.9% | 66.7% | 1.07 | 15.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/5/2026 | |||
| 10/30/2025 | 6.0% | 6.6% | 10.0% |
| 7/31/2025 | -0.9% | 3.3% | 3.5% |
| 5/1/2025 | -1.3% | -0.8% | -0.9% |
| 2/6/2025 | 1.2% | 0.7% | -6.0% |
| 10/24/2024 | -8.9% | -11.3% | -7.8% |
| 7/25/2024 | -0.6% | -1.4% | 0.2% |
| 4/25/2024 | 19.5% | 16.0% | 20.8% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 11 | 12 |
| # Negative | 13 | 13 | 12 |
| Median Positive | 3.6% | 5.8% | 7.9% |
| Median Negative | -4.7% | -6.9% | -4.8% |
| Max Positive | 19.5% | 16.0% | 20.8% |
| Max Negative | -14.4% | -13.1% | -12.5% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-Q |
| 03/31/2025 | 05/09/2025 | 10-Q |
| 12/31/2024 | 02/28/2025 | 10-K |
| 09/30/2024 | 11/01/2024 | 10-Q |
| 06/30/2024 | 08/02/2024 | 10-Q |
| 03/31/2024 | 05/03/2024 | 10-Q |
| 12/31/2023 | 02/23/2024 | 10-K |
| 09/30/2023 | 11/03/2023 | 10-Q |
| 06/30/2023 | 08/07/2023 | 10-Q |
| 03/31/2023 | 05/05/2023 | 10-Q |
| 12/31/2022 | 02/24/2023 | 10-K |
| 09/30/2022 | 11/04/2022 | 10-Q |
| 06/30/2022 | 08/05/2022 | 10-Q |
| 03/31/2022 | 05/06/2022 | 10-Q |
| 12/31/2021 | 02/25/2022 | 10-K |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Corrigan, Catherine | President & CEO | Direct | Sell | 12162025 | 70.74 | 3,225 | 228,132 | 5,951,530 | Form |
| 2 | Corrigan, Catherine | President & CEO | Direct | Sell | 11182025 | 70.39 | 4,900 | 344,898 | 5,872,354 | Form |
| 3 | Corrigan, Catherine | President & CEO | Direct | Sell | 10162025 | 66.82 | 4,930 | 329,440 | 5,529,855 | Form |
| 4 | Corrigan, Catherine | President & CEO | Direct | Sell | 9162025 | 69.91 | 4,905 | 342,903 | 5,785,161 | Form |
| 5 | Corrigan, Catherine | President & CEO | Direct | Sell | 8152025 | 71.09 | 4,896 | 348,043 | 5,782,370 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.